Abstract
Against a backdrop of a rising generics market and increasing patent expiries, the 'quality' of patents has become an ever more significant topic of debate. Pharmaceutical Patent Analyst has brought together a group of leading attorneys and IP specialists to disentangle the issue of patent quality, including its definition and importance to the field of pharmaceutical and medical science, and what steps could be taken to improve understanding of this important yet fluid concept. Interviews conducted by Alexandra Sklan, Commissioning Editor.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
